Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.
One reason that analysts and doctors want to see the data is to better understand how well the personalized treatment works.
Moderna (MRNA) stock news
Every headline mentioning Moderna from Yahoo Finance, MarketWatch and Investing.com over the last 30 days, each scored for sentiment and importance. Updated automatically through the trading day.
Headlines1last 7 days · 10 in 30 days
Sentiment, 30 days
6 positive2 neutral1 negative
Latest headlineMon 21 Sep, 20:19 UTCHealthcare
Latest MRNA headlines
Monday, 21 September 2026
Sunday, 20 September 2026
Saturday, 19 September 2026
Saturday, 12 September 2026
Thursday, 10 September 2026
Thursday, 3 September 2026
Can Moderna reclaim 52-week highs after pullback, or have best levels been seen?
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?
MRNA's newly approved mFlusiva faces a potential challenge as GSK advances an mRNA flu vaccine targeting two viral proteins.
This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks
Monday, 31 August 2026
23 best-performing stocks of August, as the software industry continues its recovery
The energy and technology sectors did well in August, while Moderna’s stock was the best performer by a wide margin.